Literature DB >> 7900627

Assessment of autonomic tone over a 24-hour period in patients with congestive heart failure: relation between mean heart rate and measures of heart rate variability.

G Panina1, U N Khot, E Nunziata, R J Cody, P F Binkley.   

Abstract

Patients with congestive heart failure (CHF) are characterized by an imbalance of the autonomic nervous system, which may contribute to the progression of circulatory failure and influence survival. However, it is still unclear whether CHF is characterized by a suppression of the diurnal variation in autonomic tone that is observed in normal subjects. To characterize the circadian variation in autonomic tone in patients with ventricular failure, ambulatory 24-hour Holter monitor recordings were obtained in 20 patients with CHF; 4-minute epochs of data from every hour of each 24-hour recording were selected. For each epoch we calculated the mean heart rate (HR) and, by applying spectral analysis of heart rate variability (HRV), we quantified the magnitude of the total (0.02 to 0.9 Hz), sympathetically governed low frequency variability (0.02 to 0.1 Hz), and parasympathetically mediated high-frequency variability (0.1 to 0.9 Hz). These areas were also expressed as a ratio to total variability and a ratio of high to low variability. A highly significant change in the mean HR over 24 hours was observed (p = 0.0001); no changes in the measures of HRV were obtained (p < 0.3). No significant correlation was found between mean HR and any frequency domain measures. We conclude that the sustained imbalance of autonomic tone over a 24-hour period, as shown by the spectral analysis of HRV, may promote the progression of circulatory failure and predispose patients with CHF to malignant ventricular arrhythmias and sudden cardiac death.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7900627     DOI: 10.1016/0002-8703(95)90325-9

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  Initial heart rate and systolic blood pressure predict outcomes in chronic heart failure patients who are evaluated for cardiac transplant.

Authors:  Juan M Aranda; Stephen E McIntyre; Charles T Klodell; Kaki M York; Carl A Dragstedt; Peter J Chaille; Jamie B Conti; Daniel F Pauly; James A Hill; Richard S Schofield
Journal:  Clin Cardiol       Date:  2007-06       Impact factor: 2.882

2.  A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence.

Authors:  Scott A Mosley; Sarah Kim; Stephan Schmidt; Larisa H Cavallari; Nihal El Rouby; Karthik Lingineni; Valvanera Vozmediano Esteban; Yan Gong; Yiqing Chen; David Estores; Kairui Feng; Hyewon Kim; Minori Kinjo; Taimour Langaee; Zhichuan Li; Siegfried O F Schmidt; Julie A Johnson; Reginald F Frye; Lanyan Lucy Fang; Liang Zhao; Philip F Binkley
Journal:  Clin Transl Sci       Date:  2022-05-21       Impact factor: 4.438

3.  Morning surge of ventricular arrhythmias in a new arrhythmogenic canine model of chronic heart failure is associated with attenuation of time-of-day dependence of heart rate and autonomic adaptation, and reduced cardiac chaos.

Authors:  Yujie Zhu; Mohamed A Hanafy; Cheryl R Killingsworth; Gregory P Walcott; Martin E Young; Steven M Pogwizd
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

4.  Variability in interbeat duration influences myocardial contractility in rat cardiac trabeculae.

Authors:  Carlos A A Torres; Kenneth D Varian; Paul M L Janssen
Journal:  Open Cardiovasc Med J       Date:  2008-11-21

5.  Evaluation of heart rate measurements in clinical studies: a prospective cohort study in patients with heart disease.

Authors:  Marco Albanese; Michaelis Neofytou; Taoufik Ouarrak; Steffen Schneider; Wolfgang Schöls
Journal:  Eur J Clin Pharmacol       Date:  2016-03-29       Impact factor: 2.953

6.  Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment.

Authors:  Nejka Potočnik; Martina Perše; Anton Cerar; Rade Injac; Žarko Finderle
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.